Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription database

(2012) Michael Pazianas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis

(2012) Frederick Wolfe et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study

(2012) L. Bondo et al.   OSTEOPOROSIS INTERNATIONAL

Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects

(2010) Zekeriya Ulger et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Incidence of Venous Thromboembolism in Users of Strontium Ranelate

(2010) Vicki Osborne et al.   DRUG SAFETY

Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis

(2010) Mark J. Bolland et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity

(2009) P. Musette et al.   OSTEOPOROSIS INTERNATIONAL